Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00092105Phase 3Completed
A Phase 3 trial of montelukast in asthma, allergic rhinitis (AR), sponsored by Organon & Co.. Started Apr 2002; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00092105.